TD Cowen Reiterates Buy Rating on GoodRx Holdings Inc. (GDRX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
GoodRx Holdings Inc. (GDRX) PT Lowered to $8 at Deutsche Bank
May 13, 2024 5:49 AM EDTDeutsche Bank analyst George Hill lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $8.00 (from $9.00) while maintaining a Hold rating.
The analyst comments "Modest Q1 Beat With Continued Margin Expansion: GDRX reported solid Q1 results with modest revenue beat and better-than-expected... More
GoodRx Holdings, Inc. (GDRX) Tops Q1 EPS by 1c ; Offers Guidance
May 9, 2024 6:15 AM EDTGoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q1 EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $197.9 million versus the consensus estimate of $196.09 million.
GUIDANCE:
GoodRx Holdings, Inc. sees Q2 2024 revenue of $200 million, versus the... More
